Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Loss of cellular viability in areas of ground-glass opacity on computed tomography images immediately after pulmonary radiofrequency ablation in rabbits.

Kuroki M, Nakada H, Yamashita A, Sawaguchi A, Uchino N, Sato S, Asanuma T, Asada Y, Tamura S.

Jpn J Radiol. 2012 May;30(4):323-30. doi: 10.1007/s11604-012-0054-y.

PMID:
22302295
2.

[Correlation between CT and pathological findings after radiofrequency ablation of rabbit lung: evaluation of therapeutic effective area].

Tominaga J, Miyachi H, Ishibashi T, Takahashi S.

Nihon Igaku Hoshasen Gakkai Zasshi. 2004 Jul;64(5):305-6. Japanese.

PMID:
15377050
3.

Percutaneous radiofrequency thermal ablation of lung VX2 tumors in a rabbit model using a cooled tip-electrode: feasibility, safety, and effectiveness.

Lee JM, Jin GY, Li CA, Chung GH, Lee SY, Han YM, Chung MJ, Kim CS.

Invest Radiol. 2003 Feb;38(2):129-39.

PMID:
12544076
4.

Percutaneous radiofrequency ablation of lung tumors in a large animal model.

Ahrar K, Price RE, Wallace MJ, Madoff DC, Gupta S, Morello FA Jr, Wright KC.

J Vasc Interv Radiol. 2003 Aug;14(8):1037-43.

PMID:
12902562
5.

18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits.

Okuma T, Matsuoka T, Okamura T, Wada Y, Yamamoto A, Oyama Y, Koyama K, Nakamura K, Watanabe Y, Inoue Y.

J Nucl Med. 2006 Aug;47(8):1351-8.

6.

Percutaneous radiofrequency ablation of lung cancer presenting as ground-glass opacity.

Iguchi T, Hiraki T, Gobara H, Fujiwara H, Matsui Y, Soh J, Toyooka S, Kiura K, Kanazawa S.

Cardiovasc Intervent Radiol. 2015 Apr;38(2):409-15. doi: 10.1007/s00270-014-0926-x. Epub 2014 Jun 18.

PMID:
24938905
7.

Radiofrequency ablation of lung tumors: imaging features of the postablation zone.

Abtin FG, Eradat J, Gutierrez AJ, Lee C, Fishbein MC, Suh RD.

Radiographics. 2012 Jul-Aug;32(4):947-69. doi: 10.1148/rg.324105181. Review.

8.

Time course of nicotinamide adenine dinucleotide diaphorase staining after renal radiofrequency ablation influences viability assessment.

Anderson JK, Baker M, Jaffers O, Pearle MS, Lindberg GL, Cadeddu JA.

J Endourol. 2007 Feb;21(2):223-7.

PMID:
17338624
9.

Percutaneous computed tomography fluoroscopy-guided conformal ultrasonic ablation of vertebral tumors in a rabbit tumor model. Laboratory investigation.

Sciubba DM, Burdette EC, Cheng JJ, Pennant WA, Noggle JC, Petteys RJ, Alix C, Diederich CJ, Fichtinger G, Gokaslan ZL, Murphy KP.

J Neurosurg Spine. 2010 Dec;13(6):773-9. doi: 10.3171/2010.5.SPINE09266.

PMID:
21121752
10.

Radiofrequency ablation of pulmonary tumors and normal lung tissue in swine and rabbits.

Nomori H, Imazu Y, Watanabe K, Ohtsuka T, Naruke T, Kobayashi T, Suemasu K.

Chest. 2005 Mar;127(3):973-7.

PMID:
15764784
11.

The efficacy of bipolar and multipolar radiofrequency ablation of lung neoplasms - results of an ablate and resect study.

Schneider T, Reuss D, Warth A, Schnabel PA, von Deimling A, Herth FJ, Dienemann H, Hoffmann H.

Eur J Cardiothorac Surg. 2011 Jun;39(6):968-73. doi: 10.1016/j.ejcts.2010.08.055. Epub 2010 Oct 18.

PMID:
20961771
12.

Radio-frequency tissue ablation of VX2 tumor nodules in the rabbit lung.

Goldberg SN, Gazelle GS, Compton CC, Mueller PR, McLoud TC.

Acad Radiol. 1996 Nov;3(11):929-35.

PMID:
8959183
13.

Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT.

Jin GY, Lee JM, Lee YC, Han YM, Lim YS.

AJR Am J Roentgenol. 2004 Oct;183(4):1013-20.

PMID:
15385295
14.

A synthetic tryptophan metabolite reduces hemorrhagic area and inflammation after pulmonary radiofrequency ablation in rabbit nonneoplastic lungs.

Nakada H, Yamashita A, Kuroki M, Furukoji E, Uchino N, Asanuma T, Asada Y, Tamura S.

Jpn J Radiol. 2014 Mar;32(3):145-54. doi: 10.1007/s11604-014-0282-4. Epub 2014 Jan 22.

PMID:
24448965
15.

Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumors.

Anderson EM, Lees WR, Gillams AR.

Cardiovasc Intervent Radiol. 2009 May;32(3):478-83. doi: 10.1007/s00270-008-9482-6. Epub 2009 Jan 6.

PMID:
19127381
16.

Radiological and pathological correlation of lung malignant tumors treated with percutaneous radiofrequency ablation.

Hataji O, Yamakado K, Nakatsuka A, Murashima S, Fujimoto H, Nishii Y, Nakahara H, Kobayashi H, Gabazza EC, Taguchi O.

Intern Med. 2005 Aug;44(8):865-9.

17.

Clinical evaluation of a novel bipolar radiofrequency ablation system for renal masses.

Okhunov Z, Roy O, Duty B, Waingankar N, Herati A, Morgenstern N, Sheikh-Fayyaz S, Kavoussi LR.

BJU Int. 2012 Sep;110(5):688-91. doi: 10.1111/j.1464-410X.2012.10940.x. Epub 2012 Mar 6.

18.

CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors.

Bojarski JD, Dupuy DE, Mayo-Smith WW.

AJR Am J Roentgenol. 2005 Aug;185(2):466-71.

PMID:
16037522
19.

Hepatic radiofrequency under CT-fluoroscopy guidance.

Laganà D, Carrafiello G, Mangini M, Lumia D, Mocciardini L, Chini C, Pinotti G, Cuffari S, Fugazzola C.

Radiol Med. 2008 Feb;113(1):87-100. doi: 10.1007/s11547-008-0224-2. Epub 2008 Feb 25. English, Italian.

PMID:
18338130
20.

Radiofrequency ablation for ground-glass opacity-dominant lung adenocarcinoma.

Kodama H, Yamakado K, Hasegawa T, Takao M, Taguchi O, Fukai I, Sakuma H.

J Vasc Interv Radiol. 2014 Mar;25(3):333-9. doi: 10.1016/j.jvir.2013.11.035.

PMID:
24581457

Supplemental Content

Support Center